{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:59:23Z","timestamp":1791302363708,"version":"4.1.0"},"reference-count":26,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.2217\/fon.13.273","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T17:48:27Z","timestamp":1391449707000},"page":"187-194","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":59,"title":["Enobosarm (GTx-024, S-22): A Potential Treatment for Cachexia"],"prefix":"10.1080","volume":"10","author":[{"given":"Reshmi","family":"Srinath","sequence":"first","affiliation":[{"name":"Johns Hopkins University School of Medicine,Division Endocrinology,Diabetes & Metabolism,\r1830 East Monument Street, Suite 333,\rBaltimore,\rMD\r21287,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dobs","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine,Division Endocrinology,Diabetes & Metabolism,\r1830 East Monument Street, Suite 333,\rBaltimore,\rMD\r21287,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,2,3]]},"reference":[{"key":"e_1_3_2_2_1_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/76.2.473"},{"key":"e_1_3_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2004.10.003"},{"key":"e_1_3_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"e_1_3_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7"},{"key":"e_1_3_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e328340c2c2"},{"key":"e_1_3_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e328300ecc1"},{"key":"e_1_3_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/83.4.735"},{"key":"e_1_3_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.09.213"},{"key":"e_1_3_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(05)80001-3"},{"key":"e_1_3_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2722"},{"key":"e_1_3_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/66.3.683"},{"key":"e_1_3_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.8.1085"},{"key":"e_1_3_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-012-1500-1"},{"key":"e_1_3_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.11.7983"},{"key":"e_1_3_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1251"},{"key":"e_1_3_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glr100"},{"key":"e_1_3_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000485"},{"key":"e_1_3_2_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.01.003"},{"key":"e_1_3_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.09.106"},{"key":"e_1_3_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2013.38.5.1970866"},{"key":"e_1_3_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00400a011"},{"key":"e_1_3_2_2_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.088344"},{"key":"e_1_3_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0034-6"},{"key":"e_1_3_2_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70055-X"},{"key":"e_1_3_2_3_2_1","unstructured":"GTx Inc. GTx Announces Late Breaker Presentation on Results from the two Phase 3 POWER Trials of enobosarm a selective androgen receptor modulator (SARM) for the prevention and treatment of muscle wasting in NSCLC patients during 2013 European Cancer Congress. 2013(9\/26) (2013). http:\/\/phx.corporate-ir.net\/phoenix.zhtml?c=148196&p=irol-newsArticle&ID=1857358&highlight="},{"key":"e_1_3_2_3_3_1","unstructured":"2013 Prohibited List World Anti-Doping Agency. www.wada-ama.org\/Documents\/World_Anti-Doping_Program\/WADP-Prohibited-list\/2013\/WADA-Prohibited-List-2013-EN.pdf"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.13.273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:43:10Z","timestamp":1719124990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.13.273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.2217\/fon.13.273"],"URL":"https:\/\/doi.org\/10.2217\/fon.13.273","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-02-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}